Products/Services Oncomatryx has developed a comprehensive pipeline of AntibodyDrug conjugates that target the tumor-associated stroma, it has shown very high efficacy in pancreas cancer-patient derived xenograft mice, with an optimal therapeutic index. Therapeutic approach is focused on novel ADC that target proteins located in the peritumoral stroma fibroblasts. A novel route to treat cancer, directed not against tumor cells, but the cells that promote their invasiveness, tumor suppression and drug resistance. Trademarks DMTXINVASCAN, DMTXBREASTSCAN, DMTX BLADDERSCAN.
Mrs. Myriam Fabre email@example.com mobile +34 687 587 493
Mr. David Raksin firstname.lastname@example.org mobile +1 415 254 8241